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Synaptic adhesion-like molecules (SALMs) are a family of cell adhesion molecules
involved in regulating neuronal and synapse development that have also been implicated
in diverse brain dysfunctions, including autism spectrum disorders (ASDs). SALMs,
also known as leucine-rich repeat (LRR) and fibronectin III domain-containing (LRFN)
proteins, were originally identified as a group of novel adhesion-like molecules that
contain LRRs in the extracellular region as well as a PDZ domain-binding tail that couples
to PSD-95, an abundant excitatory postsynaptic scaffolding protein. While studies over
the last decade have steadily explored the basic properties and synaptic and neuronal
functions of SALMs, a number of recent studies have provided novel insights into
molecular, structural, functional and clinical aspects of SALMs. Here we summarize
these findings and discuss how SALMs act in concert with other synaptic proteins to
regulate synapse development and function.
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INTRODUCTION
Synaptic adhesion molecules play important roles in the regulation of various processes involved
in synapse development and function, including early axo-dendritic contacts, maturation of early
synapses, synaptic transmission and plasticity, and synapse maintenance and elimination (Dalva
et al., 2007; Biederer and Stagi, 2008; Han and Kim, 2008; Sanes and Yamagata, 2009; Woo et al.,
2009b; Shen and Scheiffele, 2010; Siddiqui and Craig, 2011; Krueger et al., 2012; Missler et al., 2012;
Valnegri et al., 2012; Takahashi and Craig, 2013; Um and Ko, 2013, 2017; Bemben et al., 2015;
Ko J. et al., 2015; de Wit and Ghosh, 2016; Cao and Tabuchi, 2017; Jang et al., 2017; Krueger-Burg
et al., 2017; Sudhof, 2017; Yuzaki, 2018). Prototypical examples of such molecules are neuroligins
and neurexins (Sudhof, 2017). Subsequent studies have identified a large number of other synaptic
molecules, suggesting that diverse synaptic adhesion molecules may act in concert to regulate
synapse specificity, maturation and plasticity.
Synaptic adhesion-like molecules (SALMs), also known as leucine-rich repeat (LRR) and
fibronectin III domain-containing (LRFN) proteins, are a family of synaptic adhesion molecules
originally identified independently by three groups as novel cell adhesion-like molecules that bind
through their C-terminal tails to the PDZ domains of PSD-95 (Ko et al., 2006;Morimura et al., 2006;
Wang et al., 2006; Nam et al., 2011), an abundant excitatory postsynaptic scaffolding protein (Sheng
and Kim, 2011). A total of five members of the SALM family have been identified: SALM1/Lrfn2,
SALM2/Lrfn1, SALM3/Lrfn4, SALM4/Lrfn3 and SALM5/Lrfn5 (Ko et al., 2006; Morimura et al.,
2006; Wang et al., 2006; Nam et al., 2011).
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These molecules share a similar domain structure, containing
six LRRs, an immunoglobulin (Ig) domain, and a fibronectin
type III (FNIII) domain in the extracellular side, followed by
a transmembrane domain and a cytoplasmic region that ends
with PDZ domain-binding motif (Figure 1A). The PDZ domain-
binding motif is present in SALMs 1–3, but not SALM4 or
SALM5. In contrast to the extracellular domains of SALMs,
which share high amino acid sequence identities, especially in
adhesion domains, the cytoplasmic regions lack shared domains
and substantially differ in length as well as amino acid sequence,
suggesting that they may have distinct functions.
Our previous review of SALMs summarized basic and
functional characteristics of SALMs, including chromosomal
locations of the corresponding genes and exon-intron structures,
mRNA and protein expression patterns, protein–protein
interactions, and involvement in regulating neuronal and
synapse development (Nam et al., 2011). One prominent
function of SALMs is to regulate neurite outgrowth and
branching through mechanisms including lipid raft-associated
flotillin proteins (Wang et al., 2006, 2008; Swanwick et al.,
2009, 2010; Seabold et al., 2012). SALMs also regulate synapse
development and function through mechanisms involving
interactions with PSD-95 and glutamate receptors (Ko et al.,
2006; Wang et al., 2006; Mah et al., 2010).
Notably, these functional features of SALMs have been
identified mainly through in vitro studies. Recently, however,
additional studies on SALMs using in vivo approaches, such
as genetic mouse models, have provided intriguing insights
into the physiological functions of SALMs (Li et al., 2015; Lie
et al., 2016; Morimura et al., 2017). In addition, SALM3 and
SALM5, which unlike other SALMs possess synaptogenic
activities (Mah et al., 2010), have been found to interact trans-
synaptically with presynaptic LAR family receptor tyrosine
phosphatases (LAR-RPTPs; Li et al., 2015; Choi et al., 2016),
a group of adhesion molecules with cytoplasmic phosphatase
activity that are critically involved in various aspects of neuro-
and synapse development across many species (Johnson and
Van Vactor, 2003; Takahashi and Craig, 2013; Um and
Ko, 2013; Figure 1B). Moreover, two independent X-ray
crystallography studies have determined the stoichiometry
and molecular details of the interaction of SALM5 with
LAR-RPTPs (Goto-Ito et al., 2018; Lin et al., 2018). Lastly,
recent clinical studies have additionally identified associations of
SALMs with diverse neurodevelopmental disorders (Nho et al.,
2015; Rautiainen et al., 2016; Thevenon et al., 2016; Farwell
Hagman et al., 2017; Morimura et al., 2017; Bereczki et al.,
2018). This review article will summarize these new findings
and discuss how SALMs regulate synapse development and
function.
SYNAPTIC LOCALIZATION OF SALMs
As implied by the name ‘‘synaptic adhesion-like molecule’’,
it was initially unclear whether SALMs are indeed localized
at neuronal synapses and regulate synapse development and
function through cis/trans-synaptic adhesion. The first, albeit
indirect, evidence came from the fact that some SALMs
directly interact with well-known excitatory synaptic proteins,
such as PSD-95, N-methyl-D-aspartate receptors (NMDARs),
and α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
receptors (AMPARs; Ko et al., 2006; Morimura et al., 2006;
Wang et al., 2006). Functionally, SALM2, artificially clustered on
neuronal dendrites by antibody-coated beads, was shown to be
able to recruit PSD-95 and NMDARs/AMPARs (Ko et al., 2006).
In addition, SALM3 and SALM5 expressed in heterologous cells
was shown to induce presynaptic differentiation in contacting
axons of cocultured neurons in mixed culture assays (Mah et al.,
2010), in which synaptogenic activity is tested by coculturing
neurons with heterologous cells exogenously expressing synaptic
adhesion molecules (Scheiffele et al., 2000; Biederer and
Scheiffele, 2007).
More direct evidence for synaptic localization of SALMs
has come from electron microscopy, immunocytochemistry,
biochemical and proteomic analyses. One early study using
immunocytochemistry detected endogenous SALM2 signals
at excitatory, but not inhibitory, synapses in cultured rat
hippocampal neurons (Ko et al., 2006). A subsequent electron
microscopy study detected endogenous SALM4 signals
at various subcellular locations in rat brain hippocampal
neurons, including synaptic and extra-synaptic sites, pre- and
postsynaptic sites, and dendrites and axons (Seabold et al., 2008).
Biochemical experiments further demonstrated that SALMs
are enriched in the postsynaptic density (PSD)—electron-dense
multiprotein complexes at excitatory postsynaptic sites that
contain neurotransmitter receptors, adaptor/scaffolding proteins
and signaling molecules (Sheng and Sala, 2001; Sheng and
Hoogenraad, 2007); SALM1 (Wang et al., 2006), SALM2 (Ko
et al., 2006), SALM3 (Mah et al., 2010), SALM4 (Lie et al., 2016)
and SALM5 (Mah et al., 2010).
More recently, an elegant study using proximity biotinylation,
a method combining an engineered enzyme and proteomic
mapping of biotinylated proteins within 10–50 nm of a particular
bait protein in a subcellular environment (Han et al., 2017),
identified SALMs among a large number of synaptic cleft
proteins (Loh et al., 2016). Specifically, SALM1/Lrfn2 and
SALM3/Lrfn4 were found to be present in the vicinity of
LRRTM2 and LRRTM3, the reference excitatory synaptic
adhesion molecules used in this study. Another study also
using proximity biotinylation detected SALM1/Lrfn2 in close
proximity to PSD-95 (Uezu et al., 2016). However, SALMs were
not found to be close neighbors of the inhibitory adhesion
molecules, neuroligin-2 and Slitrk3, or gephyrin (Loh et al., 2016;
Uezu et al., 2016), a major inhibitory synaptic scaffolding protein
(Tyagarajan and Fritschy, 2014; Choii and Ko, 2015; Krueger-
Burg et al., 2017). These results suggest that some SALMs are
important components of excitatory synapses; however, they
do not preclude their possible presence at inhibitory synapses,
since the biotinylation approach used is likely biased toward
identification of more abundant proteins.
Collectively, these previous observations suggest that SALMs
are present or enriched at synaptic sites, but also highlight
important details that still remain to be determined, including
excitatory vs. inhibitory synaptic localization of SALMs, pre- vs.
postsynaptic localization, and changes in synaptic localization
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FIGURE 1 | Domain structure of Synaptic adhesion-like molecules (SALMs) and LAR-RPTPs. (A) Domain structure of SALMs 1–5. Note that the PDZ domain-binding
motif (PDZ-BD) is present in SALMs 1–3 but not in SALM4 or SALM5. FNIII, fibronectin III domain; Ig, immunoglobulin domain; LRR, leucine-rich repeats; NT and CT,
N-terminal and C-terminal LRR. Note that the number of LRRs in this diagram is seven, although it was suggested to be six in early studies based on amino acid
sequence analyses (Ko et al., 2006; Morimura et al., 2006; Wang et al., 2006; Nam et al., 2011). Recent X-ray crystallographic studies have identified seven LRRs in
SALM5 (Lin et al., 2018) and eight LRRs in SALM2 and SALM5 (Goto-Ito et al., 2018), which may reflect different ways of defining LRRs. (B) Domain structure of
LAR-RPTPs (LAR, PTPσ and PTPδ). D1 and D2, membrane-proximal and -distal tyrosine phosphatase domains of LAR-RPTPs; meA/B/C; mini-exon A/B/C.
during development and activity. Addressing these additional
questions could be aided by knockout (KO) animals combined
with high-quality antibodies, as well as advanced methodologies,
such as proximity biotinylation and endogenous protein tagging
using CRISPR/Cas9-mediated homology-independent targeted
integration (Suzuki et al., 2016).
TRANS-SYNAPTIC ADHESIONS OF SALMs
An early study reported that SALM3 and SALM5, but not
other SALMs, expressed in heterologous cells induce presynaptic
differentiation in contacting axons of cocultured neurons
(Mah et al., 2010). However, it has remained unclear which
presynaptic adhesion molecules mediate SALM3/5-dependent
presynaptic differentiation.
A recent study found that SALM3 interacts with presynaptic
LAR-RPTPs to promote presynaptic differentiation (Li et al.,
2015; Figure 2). This conclusion is supported by several lines
of evidence, including protein binding, cell aggregation, and
coculture assays. All three known member of the LAR-RPTP
family (LAR, PTPσ and PTPδ) can interact with SALM3.
Importantly, these interactions are regulated by alternative
splicing of LAR-RPTPs. Specifically, the splice B insert (termed
mini-exon B or meB), but not the splice A insert (meA), both of
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FIGURE 2 | Trans-synaptic, cis-, and cytoplasmic interactions of SALMs. SALMs interact trans-synaptically with presynaptic LAR-RPTPs (LAR, PTPσ and PTPδ), in
cis with AMPA/NMDA receptors and other SALM proteins, and cytoplasmically with the postsynaptic scaffolding protein PSD-95 (in the case of SALMs 1–3 but not
SALM4 or SALM5). Protein interactions are indicated by the close proximity of the indicated proteins/domains or by dotted lines. Whether SALMs directly interact
with NMDA/AMPA receptors remains to be determined. The trans-synaptic interactions between postsynaptic SALM3/5 and presynaptic LAR-RPTPs are known to
promote presynaptic differentiation, although the function of the newly identified SALM2–LAR-RPTP (PTPδ) interaction is unclear. SALM4 interacts in cis with
SALM3 to suppress the binding of SALM3 to presynaptic LAR-RPTPs and SALM3-dependent presynaptic differentiation. Postsynaptic SALM5 can also interacts
with presynaptic SALM5 in a homophilic manner, which may interfere with the trans-synaptic interaction between presynaptic LAR-RPTPs and postsynaptic SALM5.
The cis-interactions between different postsynaptic SALMs are based on both in vitro and in vivo results, and may be mediated by the SALM–SALM dimerization
revealed by X-ray crystallographic studies. Although not shown here, some LAR-RPTPs are thought to be present and function at postsynaptic sites, in addition to
presynaptic sites.
TABLE 1 | Influences of meA/B splice inserts in LAR-RPTPs on the interaction between LAR-RPTPs and SALMs.
Mini-exon Interaction and change Method Reference
MeA SALM3-LAR/PTPδ/PTPσ– Purified protein binding to cells Li et al. (2015)
SALM5-LAR –SALM5-PTPδ/PTPσ ↓ Cell aggregation Choi et al. (2016)
SALM5-PTPδ – Surface plasmon resonance Lin et al. (2018)
SALM5-PTPδ – Surface plasmon resonance Goto-Ito et al. (2018)
MeB SALM3-LAR/PTPδ/PTPσ ↑ Protein-binding assay Li et al. (2015)
SALM5-LAR/PTPδ/PTPσ ↓ Cell aggregation Choi et al. (2016)
SALM5-PTPδ ↑ Surface plasmon resonance Lin et al. (2018)
SALM5-PTPδ ↑ Surface plasmon resonance Goto-Ito et al. (2018)
No changes, increases and decreases are indicated as horizontal bars, up arrows and down arrows, respectively.
which are located in the N-terminal three Ig domains of LAR-
RPTPs, is required for the interaction with SALM3 (Table 1).
Like SALM3, SALM5 also interacts with LAR-RPTPs (Choi
et al., 2016; Figure 2). In this case, the meB splice insert
in LAR-RPTPs suppresses SALM5–LAR-RPTP interactions, an
effect opposite that of meB on SALM3–LAR-RPTP interactions.
Therefore, both SALM3 and SALM5 interact with LAR-RPTPs
in a splicing-dependent manner, although the polarity of the
modulatory effect of the insert appears to differ (but see below for
conflicting results and related structural and biochemical data).
Presynaptic LAR-RPTPs are known to interact with several
other postsynaptic adhesion molecules in addition to SALM3/5,
including NGL-3, Slitrks, TrkC, IL1RAPL1 and IL-1RAcP (Woo
et al., 2009a,b; Kwon et al., 2010; Takahashi et al., 2011,
2012; Valnegri et al., 2011; Yoshida et al., 2011, 2012; Yim
et al., 2013; Li et al., 2015); also see reviews by Craig, Ko
and colleagues (Takahashi and Craig, 2013; Um and Ko, 2013)
for further details. These results give rise to a number of
obvious questions: Why are there multiple LAR-RPTP-binding
postsynaptic adhesion molecules? Does a single synapse contain
all, or amajority, of the postsynaptic LAR-RPTP ligands? If so, do
they compete with each other for mutually exclusive LAR-RPTP
binding, or do they act in concert to fine-tune synapse regulation?
These questions can also be applied to the three presynaptic LAR-
RPTPs, LAR, PTPσ and PTPδ.
First, it seems unlikely that all three LAR-RPTPs are present
in the same synapses, in part because LAR, PTPσ and PTPδ
are differentially expressed in distinct brain regions (Kwon
et al., 2010). In addition, evidence suggests that LAR, PTPσ
and PTPδ differentially localize to and regulate excitatory
and inhibitory synapses, with PTPσ and PTPδ being more
important at excitatory and inhibitory synapses, respectively
(Takahashi et al., 2011, 2012; Takahashi and Craig, 2013;
Um and Ko, 2013); however, additional details remain to
be determined. Splice variants of LAR-RPTPs are tightly
regulated in a spatiotemporal manner (O’Grady et al., 1994;
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 April 2018 | Volume 11 | Article 105
Lie et al. SALM/Lrfn Family Synaptic Adhesion Molecules
Pulido et al., 1995a,b; Zhang and Longo, 1995). In particular,
each LAR-RPTP protein’s mini-exon profile, which strongly
influences interactions with their postsynaptic partners
(Takahashi and Craig, 2013; Um and Ko, 2013), appears to
be distinct in specific brain regions. For instance, the meB splice
insert in the rat hippocampus is almost always present in PTPδ,
but is rarely found in LAR and is only present in about half of
PTPσ molecules (Li et al., 2015), suggesting that hippocampal
SALM3 is likely to interact with LAR-RPTPs in the rank order,
PTPδ > PTPσ  LAR (Li et al., 2015). Similarly, the majority
of PTPδ splice variants in the mouse hippocampus contain the
meB splice insert (Yoshida et al., 2011). Therefore, LAR-RPTPs
are likely to interact with their postsynaptic partners in a
spatiotemporally and molecularly regulated manner.
It can also be expected that postsynaptic LAR-RPTP ligands
would be differentially expressed in specific brain regions and
cell types. In addition, each postsynaptic LAR-RPTP ligand
apparently has a unique preference for particular splice variants
of LAR-RPTPs. For instance, meB is required for (or positively
regulates) LAR-RPTP binding to SALM3, Slitrks, IL1RAPL1 and
IL-1RAcP (Yoshida et al., 2011, 2012; Takahashi et al., 2012;
Yim et al., 2013; Li et al., 2015), but inhibits LAR-RPTP binding
to TrkC (Takahashi et al., 2011). Notably, NGL-3 differs from
other postsynaptic LAR-RPTP-binding proteins in that it binds
to the first two FNIII domains of LAR-RPTPs (Woo et al.,
2009a), whereas all other such proteins bind to the N-terminal
Ig domains of LAR-RPTPs (Takahashi et al., 2011, 2012; Yoshida
et al., 2011, 2012; Yim et al., 2013; Li et al., 2015; Choi et al., 2016).
This suggests the intriguing possibility that LAR-RPTPs form
ternary protein complexes with NGL-3 and other postsynaptic
LAR-RPTP binders, and hints at the potential interplay among
these complex components. Therefore, interactions of trans-
synaptic LAR-RPTPs with their postsynaptic partners likely
occur in a precisely regulated manner.
It is thought that LAR-RPTPs are present mainly
at presynaptic sites, because LAR proteins expressed in
heterologous cells do not induce presynaptic protein clustering
at contacting axons of cocultured neurons, but do induce
postsynaptic protein clustering in contacting dendrites (Woo
et al., 2009a). However, although some light microscopy-
level immunostaining has been performed (Takahashi et al.,
2011; Farhy-Tselnicker et al., 2017), clear pre- vs. postsynaptic
localization of endogenous LAR-RPTPs has not been determined
at the electron microscopy level. In addition, postsynaptic
LAR-RPTPs have been shown to regulate dendritic spines
and AMPAR-mediated synaptic transmission (Dunah et al.,
2005). More recently, PTPδ coexpressed with IL1RAPL1 in
cultured hippocampal neurons was found to inhibit IL1RAPL1-
dependent suppression of dendritic branching, suggesting that
postsynaptic PTPδ interacts in cis with, and inhibits, IL1RAP1
(Montani et al., 2017). Therefore, it is possible that SALM3/5-
LAR-RPTP interactions also occur at postsynaptic sites in a cis
manner.
Experiments using heterologous cells and cultured neurons
have shown that SALM5 can engage in both transcellular and
homophilic adhesions (Seabold et al., 2008). This suggests that
presynaptic SALM5 may compete with presynaptic LAR-RPTPs
for binding to postsynaptic SALM5. Alternatively, these two
interactions may occur in a spatiotemporally distinct manner.
Lastly, heparan sulfate proteoglycans interact with
LAR-RPTPs in the presynaptic membrane to regulate their
interactions and functions (Aricescu et al., 2002; Johnson
et al., 2006; Song and Kim, 2013; Coles et al., 2014; Ko
J. S. et al., 2015; Farhy-Tselnicker et al., 2017; Won et al., 2017),
and thus may regulate SALM–LAR-RPTP interactions and
functions. In addition, LAR proteins associate with netrin-G1,
a glycosylphosphatidylinositol-anchored presynaptic adhesion
molecule (Nakashiba et al., 2000), at the presynaptic side when
netrin-G1 is coupled with its cognate postsynaptic ligand NGL-1
(Song et al., 2013), suggesting the possibility that trans-synaptic
SALM3/5–LAR-RPTP interactions is regulated by a neighboring
trans-synaptic netrin-G1-NGL-1 interaction.
STRUCTURES OF SALMs IN COMPLEX
WITH LAR-RPTPs
Although previous studies have identified interactions between
SALM3/5 and LAR-RPTPs, the molecular stoichiometry and
mechanistic details of these interactions have remained unclear.
Two recent X-ray crystallography studies have been instrumental
in resolving many of these uncertainties.
The first revealed that SALM5 can form a dimeric structure,
in which dimerization is mediated mainly by the N-terminal
LRR domain, and that this dimer forms a complex with two
PTPδ monomers (Lin et al., 2018; Figures 3A,B). In this
2:2 stoichiometry, a SALM5 dimer bridges two PTPδmonomers,
which are positioned at opposite sides of the SALM5 dimer.
The overall shape of the complex has two components: a central
platform-like structure formed by two antiparallel LRR domains
of SALM5 with a concave core in its center, and four leg-like
structures formed by two Ig domains of SALM5 and two
Ig3 domains of PTPδ.
It was found that the specific molecular interfaces that
mediate the SALM5–PTPδ interaction are the LRR domain
of SALM5, which interacts with the second Ig domain of
PTPδ, and the Ig domain of SALM5, which interacts with
both the second and third Ig domains of PTPδ. Importantly,
mutations in the LRR domain of SALM5 that disrupt
dimerization were shown to abolish SALM5–LAR-RPTPs
interactions and SALM5-dependent presynaptic differentiation.
Therefore, SALM5 dimerization is critical for both the trans-
synaptic adhesion and synaptogenic activity of SALM5.
These conclusions are further confirmed by a second study,
which reported a SALM5 dimer in complex with two PTPδ
monomers (Goto-Ito et al., 2018). This study identified eight
LRRs whereas the other study identified seven LRRs; notably,
both values differ from the number predicted in previous studies
(six) based on amino acid sequence analyses (Ko et al., 2006;
Morimura et al., 2006; Wang et al., 2006; Nam et al., 2011). These
differences appear to reflect the specific criteria authors used to
define LRRs in the different studies.
Intriguingly, this second study also solved the 2:2 structure
of PTPδ in complex with SALM2 (Goto-Ito et al., 2018), a
member of the SALM family that, unlike SALM3 and SALM5,
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FIGURE 3 | X-ray crystal structure of SALM5 in complex with PTPδ in a 2:2 heterotetrameric format. (A) Side view of the structure (surface representation).
(B) Top-down view of the structure (ribbon diagram). These images were borrowed without modification from Figures 1B,C of a recent report on the crystal structure
of SALM5 in complex with PTPδ (Lin et al., 2018), which are under a Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/).
has little or no synaptogenic activity (Mah et al., 2010). It is
possible that SALM2 actually has synaptogenic activity that has
gone unidentified in previous studies employing coculture assays
and neuronal overexpression (Ko et al., 2006). Alternatively,
SALM2 may interact with PTPδ to regulate other aspects of
neuronal synapses. For instance, SALM2 is capable of associating
with PSD-95 and NMDA/AMPARs (Ko et al., 2006). Therefore,
the PTPδ–SALM2 interaction may promote postsynaptic protein
clustering rather than presynaptic differentiation.
These two studies have also provided significant molecular
insights into how alternative splicing regulates SALM-LAR-
RPTP interactions. Specifically, they show that the meB, but not
meA, splice insert is located in the junctional region between
Ig2 and Ig3 domains of PTPδ, both of which are engaged in
SALM5 interactions. The meB splice insert, although not directly
interacting with SALM5, appears to function as a flexible linker
that optimizes the position of the PTPδ-Ig3 domain for its
high-affinity interaction with the SALM5-Ig domain (Goto-Ito
et al., 2018; Lin et al., 2018). This conclusion is further supported
by surface plasmon resonance assays that used purified PTPδ
proteins, with or without meB, and demonstrated that the
presence of meB increases the affinities between SALM5 and
PTPδ by ∼7–30 fold (Goto-Ito et al., 2018; Lin et al., 2018;
Table 1).
Overall, these results are in apparent contrast with an
earlier report that meB suppresses the interaction between
LAR-RPTPs and SALM5 (Choi et al., 2016). A possible reason
for this discrepancy is differences in the method used to assess
binding—cell aggregation assays in this earlier report (Choi
et al., 2016) and binding assays using purified proteins in the
more recent studies (Goto-Ito et al., 2018; Lin et al., 2018).
Indeed, the effects of meB on SALM3–LAR-RPTP interactions
were substantially weakened in cell aggregation assays relative to
protein binding assays (Li et al., 2015).
The findings of these two X-ray crystallography studies
are largely similar to those investigating other LAR-RPTP
interactions, which showed that meB is required for (or
promotes) interactions between Slitrk1 and PTPσ (Um
et al., 2014), Sltrk2 and PTPδ (Yamagata et al., 2015a), and
IL1RAPL1/IL-1RAcP and PTPδ (Yamagata et al., 2015b).
Therefore, these interactions, if present in the same synapse
together with the SALM4–LAR-RPTP complex, are likely to be
simultaneously regulated by meB.
The 2:2 stoichiometry of SALM5–LAR-RPTP interactions
that involves an antiparallel LRR dimerization, something
that is not observed in other LAR-RPTP-related crystal
structures (Coles et al., 2014; Um et al., 2014; Yamagata
et al., 2015a,b; Won et al., 2017), carries multiple potential
functional implications. One possibility is that this stoichiometry
could increase the affinity of the trans-synaptic SALM5–LAR-
RPTP interaction. Indeed, the Kd values for the SALM5–PTPδ
interaction determined in two independent studies ranged
from 0.07 µM to 14.4 µM, indicating weaker interactions
than those for LAR-RPTPs with Slitrk1, Slitrk2, IL1RAPL1,
IL-1RAcP or TrkC, which are in the sub-micromolar range
(0.15–0.55 µM). However, it remains unclear whether the
SALM5–PTPδ interactions measured under the surface plasmon
resonance condition involves the 2:2 stoichiometry.
What advantages might accrue to SALMs because they
are able to achieve an appropriate trans-synaptic affinity
through dimerization—a property lacking in other LAR-RPTP
ligands? It is possible that a SALM5 dimer brings two
PTPδ molecules close to each other to more efficiently
promote presynaptic differentiation through liprin-α. Liprin-α
belongs to a family of LAR-RPTP-binding scaffolding/adaptor
proteins whose members are known to form homodimers
and bridge LAR-RPTPs with their phospho-tyrosine protein
substrates, such as β-catenin (Serra-Pagès et al., 1995, 1998;
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Dunah et al., 2005; Stryker and Johnson, 2007; de Curtis,
2011).
On the postsynaptic side, SALM2 dimers, which are clearly
revealed in crystal structures (Goto-Ito et al., 2018), may
efficiently interact with PSD-95 and PSD-95–associated proteins
known to form dimeric/multimeric structures, such as Shank
and Homer (Kim et al., 1996; Hsueh et al., 1997; Xiao et al.,
1998; Naisbitt et al., 1999; Hayashi et al., 2009). These multimeric
interactions may facilitate the formation of platform-like multi-
protein structures in the PSD.
CIS INTERACTIONS OF SALMs
Cis-interactions of diverse synaptic adhesion molecules have
received increasing attention because they often regulate trans-
synaptic interactions as well as receptor-mediated synaptic
transmission (Jang et al., 2017). For example, neuroligin-1
interacts in cis with the GluN1 subunit of NMDARs through
extracellular domains to increase the synaptic abundance of
NMDARs (Budreck et al., 2013). In addition, postsynaptic
neurexin-1β interacts in cis with neuroligin-1 to suppress the
trans-synaptic interaction of neuroligin-1 with presynaptic
neurexins (Taniguchi et al., 2007). More recently, MDGAs
(MAM domain-containing glycosylphosphatidylinositol
anchors) have been found to interact in cis with neuroligins to
modulate trans-synaptic neuroligin–neurexin interactions (Lee
et al., 2013; Pettem et al., 2013; Elegheert et al., 2017; Gangwar
et al., 2017; Kim et al., 2017; Thoumine and Marchot, 2017).
SALMs are involved in cis-interactions in addition to trans-
interactions. The first clue came from the original study
on SALMs, which reported that SALM1 associates with and
promotes surface expression and clustering of NMDARs (Wang
et al., 2006; Figure 2). This required the C-terminal tail of
SALM1, which interacts with PSD-95 and subsequently with
GluN2B subunits of NMDARs, suggesting that SALM1 indirectly
interacts with and clusters NMDARs through PSD-95. However,
SALM1 can also associate with GluN1, a subunit of NMDARs
that lacks the cytoplasmic region, suggesting that SALM1 can
directly interact with NMDARs. Additional clues for cis-
interactions of SALMs came from the finding that bead-mediated
direct clustering of SALM2 on the dendritic surface of cultured
neurons induces secondary clustering of PSD-95 as well as
AMPA/NMDARs (Ko et al., 2006), although whether this is
mediated by direct interactions remains unclear.
A careful examination of cis-interactions between different
SALM family members showed that all SALM members
coimmunoprecipitate with each other in both a homomeric
and heteromeric manner in heterologous cells (Seabold et al.,
2008; Figure 2). The extracellular domains of SALMs are
important for these cis-interactions, as evidenced by the fact that
a SALM1mutant lacking the entire cytoplasmic domain can form
homo- and heteromultimers. In the brain, however, heteromeric
SALM complexes are formed between SALMs 1–3, but not
SALM4 or SALM5. The ability of SALM4 and SALM5, but not
other SALMs, to mediate homophilic trans-synaptic adhesion
suggests that postsynaptic SALMs can be segregated into three
subgroups: (1) SALMs 1–3; (2) SALM4; and (3) SALM5.
However, a recent study has complicated this picture,
reporting that SALM4 can coimmunoprecipitate with SALM2 in
the mouse brain (Lie et al., 2016). This study further showed that
SALM4 can also form complexes with SALM3 and SALM5 in
heterologous cells. Additional domain-mapping experiments
revealed that the LRR domain of SALM4 is important for
its interactions with SALM2/5, whereas the transmembrane
domain is important for its interaction with SALM3. Thus,
cis-interactions between SALMs may be more complex than
previously thought.
What might be the molecular mechanisms underlying the
cis-interactions of SALMs? Perhaps, the aforementioned dimeric
nature of SALMs revealed by X-ray crystallography may explain
some of these interactions. The fact that the LRR domain
of SALM4 is important for its cis-complex formation with
SALM2/5 is consistent with the critical role of LRR domains
in SALM dimerization. However, the SALM4–SALM3 cis-
interaction, which requires the transmembrane domain, is
unlikely to involve LRR dimerization.
What could be the possible functions of cis-interactions in
SALMs? If heteromeric dimerization occurs, these interactions
may increase the diversity of the subunit composition of
SALM dimers. For instance, a SALM2–SALM5 dimer might
bring SALM5 into proximity with the SALM2–PSD-95 complex
and promote SALM5-dependent presynaptic differentiation at
excitatory synapses, thereby shifting the balance of excitatory
and inhibitory synapses towards excitation. In addition, these
interactions may increase the diversity of non-SALM proteins,
including trans-synaptic adhesion proteins, cis-neighboring
membrane proteins, and cytoplasmic adaptor/signaling proteins
around SALM complexes. This, in turn, could influence the
synaptic trafficking and synapse-modulatory actions of SALMs.
IN VIVO FUNCTIONS OF SALM1/Lrfn2
As noted above, SALM1 was previously shown to be involved
in surface expression and dendritic clustering of NMDARs
(Wang et al., 2006). More recently, immunogold electron
microscopy has revealed strong colocalization of SALM1 with
the GluN1 subunit of NMDARs (Thevenon et al., 2016). These
results suggest that SALM1 promotes synaptic clustering of
NMDARs, although in vivo support for these findings has been
lacking.
A recent study reported a mouse line that lacks exon 2 of
the Lrfn2 gene encoding SALM1 (Lrfn2–/– mice; Morimura
et al., 2017; Table 2). Contrary to the expectation that Lrfn2
KO would suppress synaptic NMDAR function, Lrfn2–/– mice
displayed normal NMDAR-mediated synaptic transmission in
the hippocampus. Instead, many SALM1-lacking synapses also
lacked AMPARs, as evidenced by the slightly reduced number of
dendritic spines, but markedly reduced frequency of miniature
excitatory postsynaptic currents (mEPSCs), as well as altered
failure rates with minimal stimulation of NMDA/AMPA-evoked
postsynaptic currents (EPSCs). This suggests that many Lrfn2–/–
excitatory synapses are silent synapses, an immature form of
excitatory synapse that harbors NMDARs, but not AMPARs
(Isaac et al., 1995; Liao et al., 1995). Therefore, Lrfn2 KO appears
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TABLE 2 | Main phenotypes of SALM/Lrfn-mutant mice.
Protein/gene Main synaptic phenotypes Main behavioral phenotypes Reference
name
SALM1/Lrfn2 Spine head size ↓
Spine length ↑
Silent synapse number ↑
LTP ↑
Social interaction ↓
Repetitive behavior ↑
Acoustic startle ↑
Prepulse inhibition ↓
Morimura et al. (2017)
SALM3/Lrfn4 Excitatory synapse number ↓
LTP and LTD –
Locomotor activity ↓ Li et al. (2015)
SALM4/Lrfn3 Excitatory and inhibitory synapse number ↑
Excitatory synapse number normalized
by SALM4/SALM3
Lie et al. (2016)
double KO
to suppress synaptic delivery of AMPARs to NMDAR-only
synapses during developmental synapse maturation, rather than
acting at the previous step to suppress synaptic levels of
NMDARs. In line with this change, Lrfn2 KO causes an
increase in NMDAR-dependent long-term potentiation (LTP),
likely because silent synapses have more room to accommodate
incoming AMPARs. In addition to these functional changes at
excitatory synapses, Lrfn2–/– mice show morphological changes,
including reduced spine head size and increased spine length
(Morimura et al., 2017), suggesting that Lrfn2 KO suppresses
normal development of dendritic spines. Collectively, these
findings suggest that Lrfn2 KO suppresses both morphological
and functional maturation of excitatory synapses.
Behaviorally, Lrfn2–/– mice display autistic-like behavioral
abnormalities, including suppressed social interaction and
enhanced repetitive behaviors. They also show enhanced
acoustic startle and suppressed prepulse inhibition, suggestive
of impaired sensory-motor gating. Furthermore, using targeted
gene sequencing, this study identified point mutations of the
LRFN2 gene in individuals with autism spectrum disorders
(ASDs), and demonstrated that a missense mutation inhibits the
association of SALM1 with PSD-95. Interestingly, Lrfn2–/– mice
show enhanced spatial learning and fear memory, consistent
with the enhanced LTP observed in these mice and a report
that some individuals with LRFN2 mutations show enhanced
memory together with delayed speech development (Thevenon
et al., 2016).
IN VIVO FUNCTIONS OF SALM3/Lrfn4
Mice carrying a null mutation of the Lrfn4 gene (Lrfn4–/–
mice) have been used to investigate in vivo functions of SALM3
(Li et al., 2015). These mice show reduced excitatory synapse
number, as supported by spontaneous excitatory synaptic
transmission and electron microscopic data, but their inhibitory
synapses are minimally affected. However, NMDAR-mediated
synaptic transmission and NMDAR-dependent synaptic
plasticity—both LTP and LTD (long-term depression)—were
unaffected in Lrfn4–/– mice.
The strong influence of Lrfn4 KO on excitatory synapse
development relative to synaptic function or plasticity is
in line with the role of SALM3 as a synapse organizer
that regulates presynaptic differentiation by interacting with
LAR-RPTPs. SALM3/Lrfn4 was found to associate with 14-3-
3 andNCK signaling adaptors to regulate actin-rich lamellipodial
structures in monocytes through mechanisms involving the
Rac1 small GTPase (Konakahara et al., 2011, 2012). Given that
dendritic spines are actin-rich structures (Cingolani and Goda,
2008), LAR-RPTP–induced SALM3 clustering at postsynaptic
sites might promote 14-3-3/NCK- and Rac1-dependent actin
polymerization to promote synapse development.
Behaviorally, Lrfn4–/– mice show reduced locomotor activity
in both novel and familiar environments, but exhibit normal
anxiety-like behaviors. These mice also perform normally in
learning and memory tests, including Morris water maze, novel
object recognition, contextual fear conditioning, and T-maze
spontaneous/reward alternations. The minimal effect of Lrfn4
KO on learning and memory behaviors is in keeping with the
largely normal LTP in these mice. However, it remains unclear
how Lrfn4 KO leads to behavioral hypoactivity.
SALM3 has recently been implicated in the regulation
of epilepsy (Li et al., 2017). This study showed that
SALM3/Lrfn4 expression is significantly increased in two distinct
animal models of epilepsy, and further found that suppression
of SALM3 expression by virus-mediated SALM3 knockdown
ameliorates seizure activity as well as neuronal hyperexcitability.
These results suggest that SALM3 promotes epileptogenesis and
that its suppression has therapeutic potential.
IN VIVO FUNCTIONS OF SALM4/Lrfn3
Whether SALM4 regulates synapse development or function
has remained unclear, partly because SALM4 does not have
synaptogenic activity (unlike SALM3 and SALM5) or a PSD-95-
binding C-terminal tail (unlike SALMs1–3). However, it should
be noted that SALM4 is immunodetected in neuronal synapses
in addition to dendrites and axons (Seabold et al., 2008). A recent
study using mice lacking SALM4 (Lrfn3–/– mice) demonstrated
that SALM4 has unexpected negative effects on the density of
excitatory and inhibitory synapses (Lie et al., 2016). Specifically,
Lrfn3–/– mice display increases in the number of excitatory and
inhibitory synapses in the hippocampus, as supported by the
density of PSDs and frequency of mE/IPSCs.
This study further addressed the mechanisms underlying
the SALM4-dependent negative regulation of synapse density,
reporting that postsynaptic SALM4 interacts in cis with SALM3,
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which possesses synaptogenic activity and exhibits a highly
overlapping distribution pattern in the brain (Mah et al.,
2010; Lie et al., 2016). This cis-interaction, in turn, inhibits
the trans-synaptic interaction of SALM3 with presynaptic
LAR-RPTPs and suppresses SALM3-dependent presynaptic
differentiation (Lie et al., 2016). In support of these conclusions,
coexpression of SALM4 with SALM3 in heterologous cells
blocks binding of purified soluble LAR to SALM3 and inhibits
SALM3-dependent presynaptic differentiation in contacting
axons of cocultured neurons. Given that the transmembrane
domain of SALM4 is required for cis-interactions with
and inhibition of SALM3, it is unlikely that LRR-mediated
SALM4–SALM3 heterodimerization, if it occurs, underlies the
cis-inhibition.
Importantly, genetic support for these conclusions is provided
by SALM3/SALM4 double-KO mice, in which the increased
excitatory synapse density observed in SALM4 single-KO mice
is normalized, as supported by both electron microscopy and
mEPSC recordings (Lie et al., 2016). In contrast, double
KO does not normalize the increased density of inhibitory
synapses, suggesting that SALM4 negatively regulates inhibitory
synapses through mechanisms independent of SALM3. Because
SALM4 can also interact in cis with SALM5, which possesses
synaptogenic activity (Mah et al., 2010), SALM5 might also play
a role in SALM4-dependent regulation of inhibitory synapses. In
support of this possibility, expression of SALM3 and SALM5 in
heterologous cells and cultured neurons induces both excitatory
and inhibitory presynaptic contacts, and SALM5 knockdown
in cultured neurons suppresses both excitatory and inhibitory
synapses (Mah et al., 2010). However, whereas SALM3,
artificially aggregated on dendritic surfaces of cultured neurons,
induces secondary clustering of PSD-95, aggregated SALM5 does
not induce gephyrin clustering (Mah et al., 2010).
SALMs IN NEURODEVELOPMENTAL
DISORDERS
SALMs have been implicated in diverse neurodevelopmental and
psychiatric disorders (Table 3). LRFN2, encoding SALM1,
has recently been implicated in learning disabilities, as
TABLE 3 | Associations of SALMs/LRFNs with neurodevelopmental and
psychiatric disorders.
Gene/protein Disorders Reference
name
LRFN2/SALM1 Learning disability Thevenon et al. (2016)
Antisocial personality disorder Rautiainen et al. (2016)
ASD Morimura et al. (2017)
Schizophrenia Morimura et al. (2017)
LRFN5/SALM5 ASD Wang et al. (2009)
ASD and intellectual disability de Bruijn et al. (2010)
ASD Connolly et al. (2013)
ASD De Rubeis et al. (2014)
ASD Farwell Hagman et al.
(2017)
Schizophrenia Xu et al. (2009)
Developmental delay and seizure Mikhail et al. (2011)
Depression Nho et al. (2015)
supported by impaired working memory and executive
function in three individuals in a family with a 6p21 autosomal
dominant microdeletion (∼870 kb) encompassing three
genes, including LRFN2 (Thevenon et al., 2016). Similarly,
levels of SALM1/LRFN2 proteins were found to be
substantially decreased in postmortem brains of patients with
neurodegenerative disorders associated with cognitive declines
such as Alzheimer’s disease and Parkinson’s disease with
dementia (Bereczki et al., 2018). In addition, single nucleotide
polymorphism (SNP) analyses have linked LRFN2 with the risk
of antisocial personality disorder (Rautiainen et al., 2016). More
recently, a targeted gene sequencing strategy identified missense
mutations of LRFN2 in individuals with ASD (Morimura et al.,
2017), as noted above.
LRFN5, encoding SALM5, has been frequently associated
with ASDs. SNP analyses have linked a chromosomal locus
on 14q21.1 between FBXO33 and LRFN5 to a risk for ASD
(Wang et al., 2009). A balanced de novo t(14;21)(q21.1;p11.2)
translocation that leads to a∼10-fold reduction in the expression
of LRFN5, located ∼2 Mb from the translocation breakpoint,
was identified in a 19-year-old girl with autism and intellectual
disability (de Bruijn et al., 2010). In addition, a genome-wide
association study showed that LRFN5 is associated with a risk for
ASDs (Connolly et al., 2013). Similar results were reported in a
whole-exome sequencing study, although the association score
was not high (De Rubeis et al., 2014). More recently, family-
based diagnostic exome sequencing identified a point mutation
(p.V572X) in LRFN5 in an individual with ASD (Farwell Hagman
et al., 2017).
LRFN5 has also been implicated in other neurodevelopmental
and psychiatric disorders. For example, an ∼890-kb deletion
encompassing LRFN5 exons was identified in a girl with
developmental delay, learning disability, seizures, microcephaly
and receding forehead by high-resolution array comparative
genomic hybridization (Mikhail et al., 2011). In addition,
a high-resolution linkage analysis identified LRFN5 among
schizophrenia-related copy number variations (Xu et al.,
2009). Lastly, a recent genome-wide gene- and pathway-
based analysis identified LRFN5 as one of four depression-
associated genes (Nho et al., 2015). It is unclear why LRFN5
is frequently associated with brain disorders. Although its
synaptogenic activity might be a contributor, the fact that
SALM3, another synaptogenic SALM, is not closely associated
with brain disorders suggests against this possibility. Studies
using transgenic mice lacking Lrfn5may provide insight into this
question.
PERSPECTIVES
Since the discovery of the SALM/Lrfn family about a decade ago,
a large number of studies have elucidated basic characteristics
and functional features of SALMs. Recent reports have shed
additional light on the properties and functions of SALMs,
identifying novel presynaptic ligands (LAR-RPTPs) of SALM3/5,
resolving the crystal structures of SALMs in complex with LAR-
RPTPs, elucidating the in vivo functions of SALMs, and revealing
clinical implications of SALMs, collectively helping to better
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understand the functions of this protein family. However, our
understanding of SALMs remains at a relatively early stage,
leaving a number of questions to be explored.
For example, although SALMs can form heterodimers,
and SALM dimers can explain the reported heteromeric cis-
interactions between SALMs in the brain, it remains unclear
whether SALM family members other than SALM5 and
SALM2 form dimeric structures. It is also unclear whether
SALMs directly interact with NMDA/AMPARs and, if so,
whether these interactions regulate receptor functions or
synaptic adhesions in a reciprocal manner. Because SALM3 and
-5 are part of many LAR-RPTP–interacting postsynaptic
adhesion molecules, whether SALM3/5 has its own unique roles,
or redundant functions, remains to be determined.
In vivo functions of SALMs also require further exploration.
It will be interesting to determine whether SALMs have distinct
functions in different brain regions and cell types. Because
individual SALMs have largely unique cytoplasmic regions,
SALM-associated synaptic signaling pathways are likely to be
quite diverse. Circuit mechanisms underlying various behavioral
phenotypes of Salm-KO mice, in particular those associated with
SALM-related developmental and psychiatric disorders, also
need to be investigated. Given the rapid increase in information
on the biology and pathophysiology of SALMs, the next 10 years
are likely to witness a dramatic increase in our understanding of
this interesting family of synaptic adhesion molecules.
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